Introduction: Fatty liver is a hepatic manifestation that can occur as a result of many medical problems and the use of certain drugs. The global prevalence of fatty liver is on the rise due to the escalating obesity epidemic. CT scans have proven to be useful in noninvasively identifying the presence and determining the degree of liver fat. The aim of this study was to determine the efficacy of CT scan in the diagnosis of non-alcoholic fatty liver disease in individuals. Purpose: This study aimed to determine the effectiveness of CT scan in identifying non-alcoholic fatty liver disease in individuals. Methodology: The research was carried out in the Radiology and Imaging department of IbnSina Hospital in Dhaka, Bangladesh, spanning from January 2023 to June 2023. The study was conducted using a cross-sectional prospective design. This study encompassed a cohort of 300 individuals, all of whom were above the age of 18 and sought medical attention at the hospital for an abdominal CT scan. These individuals were suspected to have non-alcoholic fatty liver disease. The hepatic fat level in the patients was assessed using a typical CT scan methodology. The acquired data was analyzed using the Statistical Package for Social Sciences (SPSS) software, especially version 23.0. The study gained ethical clearance from the Ethics Committee of the School of Public Health & Life Science at the University of South Asia in Dhaka, Bangladesh. Findings: The study included a cumulative total of 300 individuals who were suspected to have the condition. According to age distribution, the maximum 203 (67.66%) of the patients were above 52 years and minimum 3(1%) were between (18-22) years, and followed by 44 (14.66%) (43-52) years, 36(12%), (33-42) years and 14(4.66%) (22-32) years. The majority of the patients were male 160(53.33%) and 140(46.66%) were female. Distribution by clinical presentation, the patients were suffering from Abdominal pain, Nausea-50(16.66%) Abdominal pain, Vomiting- 39(13%), Follow Up-60(20%), U. Abdominal pain-91(30.33%) U. Abdominal pain, Jaundice-53(17.66%) and U. Abdominal pain, Nausea-7(2.33%). According to the evaluation of CT scan, 189(63%) patients had fatty liver and 111(37%) patients had normal liver. Conclusion: This study investigated 63 % of the study patients were suffering from fatty liver diseases. Therefore, early detection may help them to medicate in a standard approach and to remove health effect in their day to day life.
Published in | International Journal of Medical Imaging (Volume 12, Issue 2) |
DOI | 10.11648/j.ijmi.20241202.12 |
Page(s) | 28-33 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Abdominal, CT Scan, Role Out, Diagnosis, Fatty Liver, Non-Alcoholic, Selected, Hospital
[1] | Fauci AS, B E, Kasper DL, et al., editors. Harrison’s Principles of Internal Medicine. 17. McGraw-Hill: Companies Inc.; 2008. Nonalcoholic Fatty Liver Disease; pp. 1982–83. |
[2] | Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990; 12(5): 1106-10. |
[3] | Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med. 1979; 67(5): 811–6. |
[4] | Nasrallah SM, Wills CE, Jr, Galambos JT. Hepatic morphology in obesity. Dig Dis Sci. 1981; 26(4): 325–7. |
[5] | Clain DJ, Lefkowitch JH. Fatty liver disease in morbid obesity. Gastroenterol Clin North Am. 1987; 16(2): 239–52. |
[6] | Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001; 121(1): 91–100. |
[7] | Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005; 129(1): 113–21. |
[8] | Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006; 44(4): 865–73. |
[9] | Younossi ZM, Gramlich T, Liu YC, et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol. 1998; 11(6): 560–5. |
[10] | Hamaguchi M, Kojima T, Takeda N, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007; 13(10): 1579–84. |
[11] | Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010; 363(14): 1341–50. |
[12] | Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999; 116(6): 1413–9. |
[13] | Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990; 11(1): 74–80. |
[14] | Goto T, Onuma T, Takebe K, Kral JG. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord. 1995; 19(12): 841–5. |
[15] | Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non- alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int. 2006; 26(7): 856–63. |
[16] | Shores NJ, Link K, Fernandez A, et al. Non-contrasted Computed Tomography for the Accurate Measurement of Liver Steatosis in Obese Patients. Digestive Diseases and Sciences. 2011; 56: 2145-2151. PMid: 21318585 PMCid: PMC3112485. |
[17] | Jang S, Lee CH, Choi KM, et al. Correlation of fatty liver and abdominal fat distribution using a simple fat computed tomography protocol. World Journal of Gastroenterology: WJG. 2011; 17: 3335-3341. PMid: 21876622 PMCid: PMC3160538. |
[18] | Wells MM, Li Z, Addeman B, et al. Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population. Canadian Journal of Gastroenterology & Hepatology. 2016; 2016: 4930987. PMid: 27446844PMCid: PMC4904663. |
[19] | Attar BM, Van Thiel DH. Current concepts and management approaches in nonalcoholic fatty liver disease. ScientificWorld Journal. 2013; 2013: 481893. |
[20] | Zeb I, Li D, Nasir K, Katz R, Larijani VN, Budoff MJ. Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol. 2012 Jul; 19(7): 811-8. Epub 2012 Apr 21. PMID: 22521729; PMCID: PMC3377794. |
[21] | Lee SS, Park SH, Kim HJ, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol. 2010; 52(4): 579–85. |
[22] | Davidson LE, Kuk JL, Church TS, Ross R. Protocol for measurement of liver fat by computed tomography. J Appl Physiol. 2006; 100(3): 864–8. |
[23] | Longo R, Ricci C, Masutti F, et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol. 1993; 28(4): 297–302. |
[24] | Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med. 1988; 27(2): 142–9. |
[25] | Kawata R, Sakata K, Kunieda T, Saji S, Doi H, Nozawa Y. Quantitative evaluation of fatty liver by computed tomography in rabbits. AJR Am J Roentgenol. 1984; 142(4): 741–6. |
APA Style
Abedin, M. S., Rahman, M. M., Sumon, S. R., Akanda, A. R., Ahamed, M., et al. (2024). Abdominal CT Scan Role out of Fatty Liver Disease: A Study in a Selected Hospital. International Journal of Medical Imaging, 12(2), 28-33. https://doi.org/10.11648/j.ijmi.20241202.12
ACS Style
Abedin, M. S.; Rahman, M. M.; Sumon, S. R.; Akanda, A. R.; Ahamed, M., et al. Abdominal CT Scan Role out of Fatty Liver Disease: A Study in a Selected Hospital. Int. J. Med. Imaging 2024, 12(2), 28-33. doi: 10.11648/j.ijmi.20241202.12
@article{10.11648/j.ijmi.20241202.12, author = {Mohammad Salehin Abedin and Mohammad Mojibur Rahman and Sohel Rana Sumon and Abdur Rab Akanda and Marzuk Ahamed and Mohammad Motiur Rahman and Mohammad Ripon Sikder}, title = {Abdominal CT Scan Role out of Fatty Liver Disease: A Study in a Selected Hospital }, journal = {International Journal of Medical Imaging}, volume = {12}, number = {2}, pages = {28-33}, doi = {10.11648/j.ijmi.20241202.12}, url = {https://doi.org/10.11648/j.ijmi.20241202.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20241202.12}, abstract = {Introduction: Fatty liver is a hepatic manifestation that can occur as a result of many medical problems and the use of certain drugs. The global prevalence of fatty liver is on the rise due to the escalating obesity epidemic. CT scans have proven to be useful in noninvasively identifying the presence and determining the degree of liver fat. The aim of this study was to determine the efficacy of CT scan in the diagnosis of non-alcoholic fatty liver disease in individuals. Purpose: This study aimed to determine the effectiveness of CT scan in identifying non-alcoholic fatty liver disease in individuals. Methodology: The research was carried out in the Radiology and Imaging department of IbnSina Hospital in Dhaka, Bangladesh, spanning from January 2023 to June 2023. The study was conducted using a cross-sectional prospective design. This study encompassed a cohort of 300 individuals, all of whom were above the age of 18 and sought medical attention at the hospital for an abdominal CT scan. These individuals were suspected to have non-alcoholic fatty liver disease. The hepatic fat level in the patients was assessed using a typical CT scan methodology. The acquired data was analyzed using the Statistical Package for Social Sciences (SPSS) software, especially version 23.0. The study gained ethical clearance from the Ethics Committee of the School of Public Health & Life Science at the University of South Asia in Dhaka, Bangladesh. Findings: The study included a cumulative total of 300 individuals who were suspected to have the condition. According to age distribution, the maximum 203 (67.66%) of the patients were above 52 years and minimum 3(1%) were between (18-22) years, and followed by 44 (14.66%) (43-52) years, 36(12%), (33-42) years and 14(4.66%) (22-32) years. The majority of the patients were male 160(53.33%) and 140(46.66%) were female. Distribution by clinical presentation, the patients were suffering from Abdominal pain, Nausea-50(16.66%) Abdominal pain, Vomiting- 39(13%), Follow Up-60(20%), U. Abdominal pain-91(30.33%) U. Abdominal pain, Jaundice-53(17.66%) and U. Abdominal pain, Nausea-7(2.33%). According to the evaluation of CT scan, 189(63%) patients had fatty liver and 111(37%) patients had normal liver. Conclusion: This study investigated 63 % of the study patients were suffering from fatty liver diseases. Therefore, early detection may help them to medicate in a standard approach and to remove health effect in their day to day life. }, year = {2024} }
TY - JOUR T1 - Abdominal CT Scan Role out of Fatty Liver Disease: A Study in a Selected Hospital AU - Mohammad Salehin Abedin AU - Mohammad Mojibur Rahman AU - Sohel Rana Sumon AU - Abdur Rab Akanda AU - Marzuk Ahamed AU - Mohammad Motiur Rahman AU - Mohammad Ripon Sikder Y1 - 2024/04/12 PY - 2024 N1 - https://doi.org/10.11648/j.ijmi.20241202.12 DO - 10.11648/j.ijmi.20241202.12 T2 - International Journal of Medical Imaging JF - International Journal of Medical Imaging JO - International Journal of Medical Imaging SP - 28 EP - 33 PB - Science Publishing Group SN - 2330-832X UR - https://doi.org/10.11648/j.ijmi.20241202.12 AB - Introduction: Fatty liver is a hepatic manifestation that can occur as a result of many medical problems and the use of certain drugs. The global prevalence of fatty liver is on the rise due to the escalating obesity epidemic. CT scans have proven to be useful in noninvasively identifying the presence and determining the degree of liver fat. The aim of this study was to determine the efficacy of CT scan in the diagnosis of non-alcoholic fatty liver disease in individuals. Purpose: This study aimed to determine the effectiveness of CT scan in identifying non-alcoholic fatty liver disease in individuals. Methodology: The research was carried out in the Radiology and Imaging department of IbnSina Hospital in Dhaka, Bangladesh, spanning from January 2023 to June 2023. The study was conducted using a cross-sectional prospective design. This study encompassed a cohort of 300 individuals, all of whom were above the age of 18 and sought medical attention at the hospital for an abdominal CT scan. These individuals were suspected to have non-alcoholic fatty liver disease. The hepatic fat level in the patients was assessed using a typical CT scan methodology. The acquired data was analyzed using the Statistical Package for Social Sciences (SPSS) software, especially version 23.0. The study gained ethical clearance from the Ethics Committee of the School of Public Health & Life Science at the University of South Asia in Dhaka, Bangladesh. Findings: The study included a cumulative total of 300 individuals who were suspected to have the condition. According to age distribution, the maximum 203 (67.66%) of the patients were above 52 years and minimum 3(1%) were between (18-22) years, and followed by 44 (14.66%) (43-52) years, 36(12%), (33-42) years and 14(4.66%) (22-32) years. The majority of the patients were male 160(53.33%) and 140(46.66%) were female. Distribution by clinical presentation, the patients were suffering from Abdominal pain, Nausea-50(16.66%) Abdominal pain, Vomiting- 39(13%), Follow Up-60(20%), U. Abdominal pain-91(30.33%) U. Abdominal pain, Jaundice-53(17.66%) and U. Abdominal pain, Nausea-7(2.33%). According to the evaluation of CT scan, 189(63%) patients had fatty liver and 111(37%) patients had normal liver. Conclusion: This study investigated 63 % of the study patients were suffering from fatty liver diseases. Therefore, early detection may help them to medicate in a standard approach and to remove health effect in their day to day life. VL - 12 IS - 2 ER -